- Conditions: Spinal Cord Injuries; Muscle Spasticity
Intervention:
Sponsors: University of Alberta; University of Alberta
Recruiting - verified April 2012 - Conditions: Aging; Physical Activity
Interventions: Other: Muscle strengthening exercises; Other: Muscle stretching exercise
Sponsors: University of Calgary; University of Calgary; Running Injury Clinic; Alberta Heritage Foundation for Medical Research; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Recruiting - verified April 2012 - Conditions: Supervised Physical Activity Plus Exercise Counseling; Supervised Physical Activity Plus Behavioural Counseling
Intervention: Behavioral: Trying Activity for Kidney Cancer Survivors (TRACKS) Trial
Sponsors: University of Alberta; University of Alberta
Recruiting - verified April 2012 - Condition: Total Parenteral Nutrition-induced Cholestasis
Interventions: Drug: Soybean oil based emulsion; Drug: Soybean oil based emulsion+Fish oil based emulsion
Sponsors: University Health Network, Toronto; University Health Network, Toronto; ASPEN Rhoads Research Foundation; Fresenius Kabi; University of Alberta; Foothills Medical Centre; St. Boniface General Hospital Research Centre; Hamilton Health Sciences Corporation; St. Paul's Hospital, Canada
Recruiting - verified February 2012 - Condition: Children's Distress During Flu Vaccination
Intervention:
Sponsors: University of Calgary; University of Calgary
Completed - verified February 2012 - Conditions: Spinal Cord Injuries; Muscle Spasticity
Intervention:
Sponsors: University of Alberta; University of Alberta
Active, not recruiting - verified January 2012 - Conditions: Sub-optimal Vitamin D Status; Bone Disease; Diabetic Nephropathy
Intervention: Drug: Vitamin D3
Sponsors: University of Alberta; University of Alberta
Enrolling by invitation - verified November 2011 - Condition: Breast Neoplasms
Interventions: Other: Volume of Exercise; Moderate or High Volume; Other: Aerobic Exercise; Other: Aerobic Exercise
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified September 2011 - Condition: Bowel Preparation for Colonoscopy
Interventions: Drug: Polyethylene Glycol-Based Lavage; Drug: Pico-Salax (Magnesium Citrate) plus Bisacodyl
Sponsors: University of Calgary; University of Calgary
Recruiting - verified August 2011 - Conditions: Renin Angiotensin System; Human; Renal Hemodynamics
Intervention: Dietary Supplement: Fructose
Sponsors: University of Calgary; University of Calgary
Recruiting - verified July 2011 - Condition: Prostate Cancer
Interventions: Behavioral: Telephone Implementation Intention; Behavioral: Self-completed implementation intention
Sponsors: University of Alberta; University of Alberta
Active, not recruiting - verified August 2011 - Conditions: Colorectal Neoplasms; Digestive System Diseases; Colonic Diseases; Colorectal Cancer
Intervention:
Sponsors: Exact Sciences Corporation; Exact Sciences Corporation
Recruiting - verified August 2011 - Condition: Sexual Assault
Interventions: Behavioral: Enhanced AAA Sexual Assault Resistance Education; Behavioral: Brochure
Sponsors: University of Windsor; University of Windsor; Canadian Institutes of Health Research (CIHR)
Recruiting - verified September 2011 - Condition: Patellofemoral Pain Syndrome
Intervention: Device: Knee abduction moment-reducing footwear
Sponsors: University of Calgary; University of Calgary; Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified October 2011 - Condition: Influenza
Intervention:
Sponsors: Dalhousie University; Dalhousie University; Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified June 2011 - Conditions: Depression; Depressive Symptoms; Type 2 Diabetes
Interventions: Other: TeamCare Depression Intervention; Other: Usual diabetes and depression care
Sponsors: The Alliance for Canadian Health Outcomes Research in Diabetes; The Alliance for Canadian Health Outcomes Research in Diabetes; Alberta Health & Wellness; Canadian Institutes of Health Research (CIHR)
Enrolling by invitation - verified February 2012 - Conditions: Obstructive Sleep Apnea; Hypertension; Cardiovascular Diseases; Stroke
Interventions: Other: Intermittent hypoxia; Drug: Indomethacin; Drug: Celecoxib; Drug: Placebo
Sponsors: University of Calgary; University of Calgary
Completed - verified December 2011 - Conditions: Obesity; Child
Interventions: Behavioral: Cognitive Behavioural Therapy (CBT); Behavioral: Psycho-Education Program (PEP)
Sponsors: University of Alberta; University of Alberta; Alberta Health Services; Canadian Institutes of Health Research (CIHR)
Recruiting - verified December 2011 - Conditions: Nutrition Assessment; Obesity
Intervention: Behavioral: Portion Size Measurement Aids (PSMAs)
Sponsors: University of Alberta; University of Alberta
Recruiting - verified April 2012 - Condition: Gastroparesis
Interventions: Drug: GSK962040 (5 mg tablet); Drug: GSK962040 (25 mg tablet); Drug: GSK962040 (125 mg tablet); Drug: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified April 2012 - Conditions: Asthma; Health
Intervention: Other: All patients
Sponsors: Centocor, Inc.; Centocor, Inc.
Recruiting - verified May 2012 - Conditions: Influenza, Human; Seasonal Influenza
Interventions: Biological: Quadrivalent seasonal influenza vaccine GSK2282512A; Biological: Fluarix®; Biological: Fluarix-YB; Biological: Quadrivalent seasonal influenza vaccine GSK2282512A
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified August 2011 - Conditions: Human Papillomavirus (HPV) Type 16/18 Infections; Cervical Neoplasia
Intervention: Biological: GSK580299 (Cervarix™)
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified February 2012 - Condition: Seasonal Influenza
Intervention: Biological: Fluviral
Sponsors: Dalhousie University; Dalhousie University; IWK Health Centre; Canadian Institutes of Health Research (CIHR); GlaxoSmithKline
Completed - verified June 2011 - Condition: Adverse Drug Events
Intervention: Behavioral: Medication Reconciliation
Sponsors: Westview Physician Collaborative; Westview Physician Collaborative
Active, not recruiting - verified February 2012 - Condition: Alcohol Consumption
Interventions: Behavioral: Computer-based Personalized Assessment Feedback; Behavioral: Computer-based sham
Sponsors: University of Alberta; University of Alberta; Norlien Foundation; Women and Children's Health Research Institute, Canada
Recruiting - verified April 2012 - Condition: Intubation, Intratracheal
Interventions: Other: Seldinger technique; Device: Surgical Airway Approach
Sponsors: University of Alberta; University of Alberta; Canadian Association of Emergency Physicians
Completed - verified October 2011 - Conditions: Cardiomyopathy; Pregnancy
Intervention:
Sponsors: University of Pittsburgh; University of Pittsburgh; National Institutes of Health (NIH)
Recruiting - verified March 2012 - Condition: Levels of Fatty Acids in the Blood Cells of Infants
Intervention:
Sponsors: Mead Johnson Nutrition; Mead Johnson Nutrition; University of Alberta
Recruiting - verified November 2011 - Condition: Portal Hypertension
Intervention: Drug: Probiotic
Sponsors: University of Alberta; University of Alberta
Completed - verified January 2012 - Condition: Idiopathic Intracranial Hypertension
Interventions: Drug: Acetazolamide; Drug: Placebo; Behavioral: Formal weight loss counselling program
Sponsors: St. Luke's-Roosevelt Hospital Center; St. Luke's-Roosevelt Hospital Center; National Eye Institute (NEI); University of Rochester; University of Iowa; University of California, Davis
Recruiting - verified May 2012 - Condition: Inflammatory Bowel Disease
Interventions: Device: Confocal endomicroscopy; Device: Confocal endomicroscopy
Sponsors: University of Alberta; University of Alberta
Recruiting - verified April 2012 - Conditions: Chronic Rhinosinusitis With Polyposis; Chronic Hyperplastic Sinusitis
Interventions: Drug: Tranexamic Acid; Drug: Normal Saline (placebo)
Sponsors: University of Alberta; University of Alberta
Completed - verified April 2012 - Condition: Hypercholesterolemia
Intervention: Dietary Supplement: LIP-01
Sponsors: Afexa Life Sciences Inc; Afexa Life Sciences Inc
Completed - verified January 2012 - Condition: Meningococcal C Disease
Intervention: Biological: Neisvac-C (Meningococcal C Conjugate Vaccine)
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified March 2012 - Conditions: Prostate Cancer; Sexual Dysfunction
Interventions: Drug: tadalafil; Other: placebo
Sponsors: National Cancer Institute (NCI); Radiation Therapy Oncology Group; National Cancer Institute (NCI)
Active, not recruiting - verified February 2012 - Condition: Obesity
Interventions: Other: Nutrition counseling + portion control tool; Other: Nutrition counseling
Sponsors: University of Calgary; University of Calgary
Recruiting - verified October 2011 - Condition: Hypertension
Interventions: Other: Enhanced pharmacist care; Other: Usual Care
Sponsors: University of Alberta; University of Alberta; Canadian Institutes of Health Research (CIHR)
Recruiting - verified April 2012 - Condition: Diabetes Mellitus
Interventions: Behavioral: High volume combined aerobic/resistance exercise; Behavioral: Low volume combined aerobic/resistance exercise; Behavioral: High volume combined A/R exercise, printouts, pedometers; Behavioral: Low volume combined A/R exercise, printouts, pedometers; Behavioral: Printed PA information, pedometers and step log group; Behavioral: Control
Sponsors: University of Calgary; University of Calgary
Active, not recruiting - verified August 2011 - Condition: Heart Failure
Intervention:
Sponsors: Medtronic Cardiac Rhythm Disease Management; Medtronic Cardiac Rhythm Disease Management
Recruiting - verified December 2011 - Condition: Glioma
Intervention:
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified April 2012 - Conditions: Triage; Pediatrics
Intervention:
Sponsors: St. Justine's Hospital; St. Justine's Hospital; SickKids Foundation; Canadian Institutes of Health Research (CIHR)
Completed - verified July 2011 - Condition: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Intervention: Biological: GSK580299, GSK Biological's HPV vaccine
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified April 2012 - Condition: Venous Thromboembolism
Intervention: Drug: Tinzaparin
Sponsors: University of Calgary; University of Calgary; LEO Pharma
Completed - verified September 2011 - Condition: Influenza Virus
Interventions: Biological: GSK Biologicals' influenza vaccine GSK1557482A; Biological: Vaxigrip
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified November 2011 - Conditions: Poliomyelitis; Haemophilus Influenzae Type b Disease; Hepatitis B; Diphtheria; Pertussis; Tetanus
Intervention: Biological: Infanrix™ hexa
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified August 2011 - Condition: Ventricular Function, Left
Interventions: Procedure: Cardiac magnetic Resonance study; Procedure: Blood testing
Sponsors: University of Calgary; University of Calgary
Terminated - verified October 2011 - Condition: Low-Income Population
Interventions: Behavioral: Control Model (EXIST); Behavioral: Primary Health Care Model; Behavioral: Recreation Coordination Model (REC); Behavioral: Comprehensive Model (COMP)
Sponsors: University of Alberta; University of Alberta
Completed - verified November 2011 - Conditions: Cognition; Aging
Interventions: Drug: tamoxifen; Drug: raloxifene
Sponsors: Wake Forest University; Wake Forest University; National Institute on Aging (NIA)
Completed - verified May 2008 - Conditions: Acute Coronary Syndrome; Myocardial Infarction; Smoking
Interventions: Drug: Bupropion HCl ER; Drug: Placebo
Sponsors: McGill University; Mark Eisenberg; Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Quebec
Completed - verified May 2008 - Condition: Vasomotor Symptoms
Interventions: Drug: desvenlafaxine succinate (DVS) SR; Drug: Placebo
Sponsors: Pfizer; Pfizer
Completed - verified July 2011 - Condition: Kidney Transplant
Intervention:
Sponsors: University of Alberta; University of Alberta
Completed - verified September 2011 - Condition: Asthma
Interventions: Drug: MEDI-563; Drug: MEDI-563; Other: Placebo Comp.; Other: Placebo
Sponsors: MedImmune LLC; MedImmune LLC
Completed - verified October 2011 - Condition: Hernia
Intervention:
Sponsors: Ethicon, Inc.; Ethicon, Inc.
Recruiting - verified April 2012 - Conditions: Vascular Diseases; Myocardial Ischemia
Interventions: Drug: adenosine; Other: modified end-tidal forcing system; Other: arm cuff occlusion; Device: Breathing gas; Device: Blood pressure cuff
Sponsors: University of Calgary; University of Calgary
Completed - verified October 2011 - Condition: Endothelial Function
Intervention: Other: ischemia reperfusion
Sponsors: University of Calgary; University of Calgary
Completed - verified October 2011 - Conditions: Deglutition Disorders; Dysphagia; Stroke
Intervention: Other: TOR-BSST© Refresher Training
Sponsors: University Health Network, Toronto; University Health Network, Toronto; Ontario Ministry of Health and Long Term Care
Completed - verified January 2012 - Condition: Neoplasms
Intervention: Drug: Dichloroacetate
Sponsors: Alberta Health Services; Alberta Health Services
Active, not recruiting - verified January 2012 - Conditions: Cervical Cancer; Papillomavirus Infection
Intervention: Biological: GSK Bio's HPV vaccine 580299 (Cervarix TM)
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified November 2011 - Condition: Contraception
Interventions: Drug: G04209F; Drug: G04209G
Sponsors: Bayer; Bayer
Active, not recruiting - verified April 2012 - Condition: Type 1 Diabetes Mellitus
Interventions: Procedure: Islet transplant; Drug: Belatacept; Drug: Basiliximab; Drug: Mycophenolate Mofetil
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified October 2011 - Condition: Metastatic Breast Cancer
Intervention:
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified December 2011 - Conditions: Rubella; Varicella; Mumps; Measles
Interventions: Biological: MeMuRu-OKA (study vac); Biological: MMR, Varicella vacc (control)
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified September 2011 - Condition: Atrial Fibrillation
Interventions: Drug: Simvastatin; Drug: Placebo
Sponsors: University of Calgary; University of Calgary; Merck; Canadian Institutes of Health Research (CIHR)
Recruiting - verified December 2011 - Condition: Healthy
Intervention:
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified December 2011 - Condition: Healthy
Intervention:
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified March 2012 - Condition: Healthy
Intervention:
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified April 2012 - Condition: Healthy
Intervention:
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified January 2012 - Condition: Healthy
Intervention:
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified March 2012 - Condition: Prophylaxis for HPV Infections and Associated Cervical Neoplasia
Interventions: Biological: Cervarix; Biological: Placebo control
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified February 2012 - Condition: Respiratory Tract Infection
Interventions: Dietary Supplement: COLD-fX natural health product; Dietary Supplement: COLD-fX; Other: Placebo
Sponsors: Capital Health, Canada; Capital Health, Canada; Afexa Life Sciences Inc; IWK Health Centre; Sunnybrook Health Sciences Centre; Erasmus Medical Center; University of BC Gerontology & Diabetes Research
Completed - verified July 2011 - Condition: Herpes Simplex
Intervention: Biological: GSK208141 vaccine
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified September 2011 - Condition: Herpes Simplex
Interventions: Biological: GSK208141; Biological: HavrixTM (investigational formulation); Biological: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified April 2012 - Condition: Dyslipidaemias
Interventions: Drug: GW590735; Drug: fenofibrate
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified April 2012 - Condition: Prostate Cancer
Intervention: Procedure: Hypofractionated radiotherapy
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified October 2011 - Conditions: Human Papillomavirus (HPV) Infection; Cervical Neoplasia
Interventions: Biological: Cervarix™; Biological: Havrix™-based investigational formulation
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified February 2012 - Condition: Papillomavirus Infection
Intervention: Biological: HPV 16/18 VLP AS04
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified October 2011 - Conditions: Depressive Disorder, Major; Major Depressive Disorder (MDD)
Intervention: Drug: GW679769
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified February 2012 - Condition: Leukemia
Interventions: Drug: asparaginase; Drug: busulfan; Drug: cyclophosphamide; Drug: cyclosporine; Drug: cytarabine; Drug: daunorubicin hydrochloride; Drug: etoposide; Drug: gemtuzumab ozogamicin; Drug: methotrexate; Drug: mitoxantrone hydrochloride; Procedure: allogeneic bone marrow transplantation
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Completed - verified November 2010
 |
Join Clinical Trials for Healthy Volunteers in Alberta |
